Breadcrumb Home Studies Studies Search Filter Research Area All Study Status AllClosed to AccrualClosed to Follow UpConcludedEnrollingIn DevelopmentOpen to AccrualParticipants Off Study and Primary Analysis CompletedPendingWithdrawn Sort Study Number AscStudy Number Desc Submit Search Showing 12 studies. P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis Pagination Previous page Prev Page 1 Current page 2
P1112: Monoclonal Antibody PK Study DAIDS Number 11903 Research Area Therapeutics Study Status Participants Off Study and Primary Analysis Completed
P1108: A Phase I/II, Open-Label, Single Arm Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Bedaquiline (BDQ) Given in Combination with an Individualized Rifampin-Resistant Tuberculosis (RR-TB) Therapy in Infants, Children and Adolescents with RR-TB Disease, Living with or without HIV. DAIDS Number 11884 Research Area Tuberculosis
